Estimation of cancer susceptibility and risk of head and neck carcinoma by gene polymorphism and expression.
Estimation of cancer susceptibility and risk of head and neck carcinoma by gene polymorphism and expression.
批准号:
15591826
负责人:
NAKAI Shigeru
金额:
$1.73万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Genetic differences in the ability to metabolize carcinogens, repair DNA damage and induce apoptosis may contribute to the variation in cancer risk in population at large. The capacity of DNA repair genes may a play important role in carcinogenesis with Tabacco- related cancer. We hypothesize that inherited polymorphisms of XPD/ERCC2 exson 23 and XRCC1 codon 26304 may contribute to genetic susceptibility to SCCHN. These polymorphisms were investigated with PCR-RFLP method. The result of XPD/ERCC2 exson 23 polymorphisms are below, control : wild home type 27 cases (93.1%), hetero type 2 cases (6.9%), mutant type 0 case (0%), patient (laryngeal carcinoma ; SCC) : wild home type 54 cases (91.5%), hetero type 5 cases (8.5%), mutant type 0 case (0%). The result of XRCC1 codon 26304 polymorphisms are below, control : wild home type 25 cases (86.2%), hetero type 4 cases (13.8%), mutant type 0 case (0%), patient : wild home type 52 cases (88.1%), hetero type 6 cases (10.2%), mutant type 1 case (1.7%). There were no signicicant between XPD/ERCC2, XRCC1 polymorphisms and susceptibility to laryngeal carcinoma. We concluded that these polymorphisms are not indicator of susceptibility to Tabacco- related cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Expresion of platelet aggregation factor Aggrus in head and neck cancer
-
批准号:18591879
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.39万
-
财政年份:2006
-
负责人:NAKAI Shigeru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
XPD-like 亚家族解旋酶对核酸底物解链的分子机制
-
批准号:LQ22C050002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:程凯莹
-
依托单位:
着色性干皮病基因XPD及其相关蛋白参与线粒体DNA氧化损伤修复的分子机制
-
批准号:31570815
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2015
-
负责人:赵永良
-
依托单位:
解旋酶WRN、XPD基因甲基化在苯致血液损伤中的作用研究
-
批准号:81360437
-
项目类别:地区科学基金项目
-
资助金额:45.0万元
-
批准年份:2013
-
负责人:肖芸
-
依托单位:
核苷酸切除修复因子XPD通过靶向HBx阻遏HBV整合
-
批准号:81360363
-
项目类别:地区科学基金项目
-
资助金额:50.0万元
-
批准年份:2013
-
负责人:郑剑锋
-
依托单位:
XPD修复酶在糖尿病加重局麻药神经毒性作用中的机制研究
-
批准号:81271390
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2012
-
负责人:徐世元
-
依托单位: